Pasteur Institute's news

Filter news

cooperation
News
24.07.2023
Innovation
Framework Agreement between the Institut Pasteur and Fiocruz for the Development of Innovation and Technology Transfer
The Institut Pasteur and the Oswaldo Cruz Foundation (Fiocruz) have a long-standing partnership, mirroring the strong...
See the news
News
04.07.2023
Innovation
Extension of the Scope of the Exclusive Licence Granted by Institut Pasteur to Meletios Therapeutics for the Development of a New Class of Antivirals
The licensing agreement signed in 2022 between Institut Pasteur and Meletios Therapeutics, a French biotechnology...
See the news
News
14.06.2023
Innovation
DARRI at the Hellenic Pasteur Institute: Innovation and Technology Transfer Workshop
From June 26 to 29, 2023, The Hellenic Pasteur Institute, member of the Pasteur Network, is organizing a workshop on...
See the news
News
08.06.2023
Innovation
Virtual Reality Surgical Planning: AVATAR MEDICAL receives FDA Clearance
On June 8, 2023, AVATAR MEDICAL, a spin-off of the Institut Pasteur and Institut Curie, both granted with the Carnot...
See the news
News
07.06.2023
Innovation
New Online Certificate In Healthcare Entrepreneurship
The Institut Pasteur and ESCP Business School in Paris have developed a new online program for learners preparing to...
See the news
Quartier Gerland, Lyon
News
23.05.2023
Innovation
Creation of an European Biocluster for Emerging Infectious Diseases
The project "Biocluster Français pour l’Innovation en Infectiologie" (BCF2I) has been selected for the Healthcare...
See the news
AVATAR MEDICAL Team
News
09.02.2023
Innovation
AVATAR MEDICAL, laureate of the EIC Accelerator, a new step forward in bringing medical imaging at the heart of the surgical practice
AVATAR MEDICAL, spin-off from the Institut Pasteur and Institut Curie, two institutes with the Carnot label, was...
See the news
Macrophage humain infecté par le virus Lassa (Arénavirus)
News
06.01.2023
Innovation
Development of a pentavalent vaccine against New World arenaviruses
An Institut Pasteur team has successfully developed a pentavalent vaccine against the five pathogenic arenaviruses...
See the news
Anticorps SARS-CoV-2
News
07.12.2022
Innovation
SpikImm receives a major funding to accelerate the clinical and industrial development of its monoclonal antibodies against SARS-CoV-2
  SpikImm, a biotech company founded in 2021 by Truffle Capital in collaboration with the Institut Pasteur, has been...
See the news

Pages

Back to top